Director/PDMR Shareholding

RNS Number : 0758F

GlaxoSmithKline PLC

05 January 2010

 



Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.

On 31 December 2009, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary shares and American Depository Shares (ADSs) in the Company through the annual reinvestment of dividends paid throughout 2009:

GlaxoSmithKline Non-Executive Directors Automatic Share Award and Elected Share Award - Annual Dividend Reinvestment

Non-Executive Director	No. of Ordinary Shares	Average  Price (£)	No. of ADSs	Average Price ($)
Sir Christopher Gent	1,822.44	13.25
Prof Sir Roy Anderson	151.12	13.25
Dr Stephanie Burns			158.38	42.40
Mr Lawrence Culp			717.14	42.40
Sir Crispin Davis	1,501.48	13.25
Sir Deryck Maughan			628.85	42.40
Mr James Murdoch	2.13	13.25
Dr Daniel Podolsky			263.63	42.40
Mr Tom de Swaan	277.24	13.25
Sir Robert Wilson	424.27	13.25

The Company and the Non-Executive Directors were informed of these allocations on 4 January 2010.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

S M Bicknell

Company Secretary

5 January 2010

---

 

END

 

 

RDSQELFBBFFXBBF